News
StockStory.org on MSN18h
Earnings To Watch: Sarepta Therapeutics (SRPT) Reports Q1 Results TomorrowBiotech company Sarepta Therapeutics (NASDAQ:SRPT) will be reporting results tomorrow after market hours. Here’s what to look ...
StockStory.org on MSN18h
What To Expect From Myriad Genetics’s (MYGN) Q1 EarningsGenetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting results tomorrow after the bell. Here’s what to look ...
PTC Therapeutics, Inc.’s PTCT share price has dipped by 21.98%, which has investors questioning if this is right time to buy.
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the first quarter of 2025, along with recent ...
Capricor Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside experts ...
CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.
Florida Polytechnic University reached a significant milestone on Sunday, May 4, as it celebrated its largest commencement ceremony to date. More than 330 students earned in-demand degrees at the ...
Midfielder Thompson, a Manchester United academy graduate who also spent three seasons with Scottish giants Rangers, made 23 ...
BioCryst Pharmaceuticals, Inc.’s BCRX share price has surged by 14.00%, which has investors questioning if this is right time to sell.
"RetinalGenix intends to expand Institutional Review Board (IRB) approval of a clinical study to include multiple practices.
Liquidia Corporation (NASDAQ: LQDA) has recently announced a significant development in its legal dispute with United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results